Human erythroblasts with c-Kit activating mutations have reduced cell culture costs and remain capable of terminal maturation

Tyler Couch(University of Rochester), Laurie A. Steiner(University of Rochester Medical Center)
Experimental Hematology
April 17, 2019
Cited by 13


Related Papers